miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 17, 2026

Walmart and Amazon are part of Zacks Earnings Preview

View original at finance.yahoo.com
Walmart and Amazon are part of Zacks Earnings Preview For Immediate Release Chicago, IL – February 17, 2026 – Zacks.com releases the list of companies likely to issue earnings surprises…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Total earnings for 13 Retail sector S&P 500 companies that have reported Q4 results are up +6.3% from the same period last year on +11.6% higher revenues, with 46.2% beating EPS estimates and 76.9% beating revenue estimates

    80% confidence
  • Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year with average gains of +48.4%, +50.2% and +56.7% per year

    80% confidence
  • Results likely benefited from pulled-forward demand in anticipation of tariffs, particularly in some categories like electronics

    80% confidence
  • Q1 estimates have come down for 10 of the 16 Zacks sectors, with the biggest declines at the Energy, Medical, and Consumer Discretionary sectors

    80% confidence
  • Walmart has consistently flagged market-share gains across all income categories, particularly in the high-income category

    80% confidence
  • Total earnings for 371 S&P 500 members are up +12.8% from the same period last year on +8.8% higher revenues, with 75.5% beating EPS estimates and 72.5% beating revenue estimates

    80% confidence
  • The Q4 EPS beats percentage at 46.2% matches the lowest beats percentage for this group of Retail sector companies in the preceding 20-quarter period

    80% confidence
  • Management has reiterated its commitment to maintain price advantage over rivals

    80% confidence
  • Walmart's e-commerce business in the U.S. is now profitable and will likely become a significant contributor to earnings in 2026 and beyond

    80% confidence
  • 2026 Q1 estimates have increased modestly for 5 of the 16 Zacks sectors since the start of January, including Tech, Industrials, Retail, Utilities, and Business Services

    80% confidence
  • Roughly two-thirds of U.S. sales were from domestically sourced products, which gave them a degree of insulation from the tariffs issue compared to others

    80% confidence
  • Walmart shares have handily outperformed not just the broader market indexes and brick-and-mortar retail peers but also Amazon and many members of the Magnificent 7 group

    80% confidence
  • E-commerce accounts for an estimated 15% of total ex-gasoline sales at present, which management sees eventually increasing to more than double that level over time

    80% confidence

Data points we hold from this source

Walmart Inc. · domestic sourcing percentage66.67 percent
Walmart Inc. · same store sales us ex fuel4.9 percent
Walmart Inc. · revenue189.9 billion_USD
Walmart Inc. · e commerce share of sales15 percent
Walmart Inc. · grocery share of sales60 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com